Regenicin Inc (EM) (RGIN)

Made Scientific and Regenicin Announce Manufacturing Relationship to Advance NovaDerm Toward FDA Product Approval
Made Scientific, Inc. (PRNewsfoto/Made Scientific, Inc)
News provided by
Made Scientific, Inc.
Apr 22, 2026, 09:30 ET

Share this article

Made Scientific to support clinical manufacturing of NovaDerm, an autologous cultured skin substitute for the treatment of severe burns and chronic wounds

PRINCETON, N.J., April 22, 2026 /PRNewswire/ -- Made Scientific, Inc., a U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Regenicin, Inc., a biotechnology company specializing in the development and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, today announced a manufacturing relationship to advance NovaDerm, an autologous cultured skin substitute for severe burns and chronic wounds, toward a U.S. FDA Orphan product approval.

Under the agreement, Made Scientific will serve as the manufacturing partner for NovaDerm, providing end-to-end services at its Princeton, New Jersey GMP facility. The program establishes a clear pathway from technology transfer through GMP clinical production and regulatory support of Regenicin's Investigational New Drug (IND) submission and upcoming clinical trial.

"We are proud to work with Regenicin to advance NovaDerm into the clinic," said Syed T. Husain, Chairman and CEO of Made Scientific. "This collaboration reflects the strength of our manufacturing platform and our ability to execute complex autologous programs with the precision and regulatory rigor required for clinical success."

"Manufacturing a patient-specific treatment like NovaDerm requires a level of consistency and traceability that few CDMOs can deliver. Made Scientific's proven expertise in autologous manufacturing gives us confidence as we move toward our IND submission and first-in-human clinical trial," said Dr. K. E. Castro, PhD, Director of Clinical Studies at Regenicin.

With industry-leading development and manufacturing capabilities and continued investment in state-of-the art infrastructure and technology, Made Scientific remains focused on its mission to defy limits and deliver results.

About Made Scientific

Made Scientific is a U.S.-based cell therapy contract development and manufacturing organization (CDMO) specializing in the development, manufacturing, and release of autologous and allogeneic cell therapy products for clinical and commercial supply. Headquartered in Princeton, New Jersey, Made Scientific combines the agility of a specialist CDMO with the deep technical expertise to deliver reliable and scalable solutions, supported by their long-term strategic backer, GC Corporation, a global leader in the pharmaceutical and biotechnology sectors. For more information, visit madescientific.com.

About Regenicin

Regenicin, Inc. (www.Regenicin.com) is a biotechnology company dedicated to advancing regenerative cell therapies to repair and restore damaged tissues and organs. Founded in 2010, Regenicin has built a world-class management team with a strong track record in developing and commercializing innovative medical devices and biotechnology products. The company is focused on bringing NovaDerm®—a breakthrough autologous cultured skin substitute—to market. NovaDerm® is a tissue-engineered skin graft that utilizes a patient's own skin cells to create living, regenerative skin for treating severe burns and chronic wounds, while requiring less tissue harvesting and reducing days of hospitalization for patients.

Media Contacts

Made Scientific

media@madescientific.com | LinkedIn: @MadeScientific

Regenicin

Info@Regenicin.com | LinkedIn: @Regenicin

SOURCE Made Scientific, Inc.

Nope, not to my knowledge. The website was updated earlier this year and now reflects Nevada instead of New Jersey. I sent them an email earlier this year and got no response. I monitor the search daily for any change and haven't seen anything.

Any updates?

https://last10k.com/sec-filings/1412659/0001662252-24-000014.htm

This came out this week.
https://last10k.com/sec-filings/1412659

Regenicin has NT7 business license(sole proprietorship) in Nevada.What does it mean?. Is corporation still exist?

No idea, m8. That last post from May is the newest thing I've seen. I look it up for news almost daily and haven't seen anything.

What's happening with clinical trials ?. Did clinical trials start or just another bluff?.

This popped up today: https://www.einnews.com/pr_news/712073973/regenicin-inc-obtains-sufficient-funding-from-product-pre-sales-to-begin-engineering-runs-on-novaderm-manufacturing

Anyone heard from the company?

Is RGIN in business?

Amazing that this is still trading. They keep their filings current, but no news in YEARS.

It's nice to see a little movement. What's going on with it? Still no news i've heard in years.

Overview



During the quarter ended, December 31, 2019, the Company continued to position its product, NovaDerm®, to enter clinical trials to gain FDA product approval. Having secured Orphan Drug Designation as a biologic for NovaDerm®, we complied with the FDA annual reporting requirements. In addition, as part of an asset purchase agreement, we granted Amarantus Bioscience Holdings, Inc., a right of first refusal for the purchase of any engineered skin technology designed for treatment of severe burns in humans that we developed. This right of first refusal expired during this quarter on November 7, 2019.



Recently, the risk of introducing pathogens when using materials from animals to produce drugs, devices, and biologics has increased awareness of the safety issues. NovaDerm® and future Regenicin products use animal sourced materials like collagen to produce the life-saving products. We have worked with our collagen supplier and the FDA to ensure we are meeting the expectations for traceability and purity of the FDA for NovaDerm® production. We have arranged for sufficient Bovine Closed Herd corium to produce sufficient collagen scaffolds to meet our needs for the clinical trials, ensuring compliance with FDA requirements.



Our major objective for 2021 is to secure the required funding to finalize some additional requirements of the IND application and begin the clinical trials. As previously reported, our goal in obtaining the required funding has been to minimize shareholders’ dilution as much as possible. Consequently, we are primarily pursuing financing through the issuance of debt instruments, international licensing agreements and governmental grants. We have completed all the administrative requirements to allow us to apply for grants. Regenicin is now registered with System For Award Management (“SAM”) which is required to do business with the US Government. We must have our IND submitted before we can request financial assistance from The US FDA Office of Orphan Products Clinical Trials Grant. We intend to take full advantage of working with OOPD to develop our clinical protocol according to suggestions from the FDA during our Pre-IND meeting.



The Orphan Drug Act created the Orphan Product Grants Program, which is administered by OOPD, to stimulate the development of promising products for rare diseases and conditions. Orphan product grants are a proven method of fostering and encouraging the development of new safe and effective medical products for rare diseases and conditions. These grants support new and continuing extramural research projects that test the safety and efficacy of promising new drugs, biologics, devices, and medical foods through human clinical trials in very vulnerable populations often with life-threatening conditions.

Here's their most recent filing: https://yahoo.brand.edgar-online.com/DisplayFiling.aspx?TabIndex=2&dcn=0001662252-21-000007&nav=1&src=Yahoo

I was shocked to see that RGIN is still filing 10Qs and 10-Ks. They've been radio silent for three years now. Why keep filing if there is no hope in moving PermaDerm forward?

Good volume. May be the time to buy

What happened here? It's only been 9 years of trying to raise $3M. By now he has asked everyone in the world. No takers. So apparently the world doesn't need this because for the last 9 years other products have been used. So is everyone sitting on their shares since so low? 154M outstanding and no one once to trade it around for fun!!!

...and so is this board

I guess regenicin and pure med farma are dead men walking....

Classic today - the bid is .0001c, the offer is 200c...... I'm going out on a limb and say the .0001 is value.

Good summary Scottrader, the only person this thing has helped is McCoy. Pure scam.

Shareholders might as well sell out recouping what ever pennies are left of their dollar investment. Just look at the company progress, the PR's of achievement the quarterly and annual filings to see this one is a loser stock only lining the pockets of fatboy McCoy.

There are other companies actively using a derma product while McCoy continues to develop his product on paper that NO ONE seems to want.

It was a good story line, helping burn victim and Veterans, unfortunately that story line is useless, no one has been helped besides McCoy.

The only thing RGIN shareholders have banked on so far is the prospect of Hope,

Hope doesnt pay the bills

Could not agree with you more applevision. It amazes me. Even on this msg board, - on the company summary above, showing 5% shareholders, there are 2 Discala entities right there. If that doesn't scare everyone for miles, I don't know what would. I've concluded that this is the downside of the bell curve - always someone at one end or the other that will believe anything. I guess these are the same people who believe in chemtrails, and that the earth is flat. Lucky we are not all the same I guess.....

If you haven't figured out from submitted quarterly forms.
This is a pure scam. Deliberate false information and operating cash flow of a lemonade stand on the farthest cul-de-sac from civilization you can find.
This D-Bag has been milking this for over a decade

Agree that today was a nice surprise. Something around 5$ would be even better.

Well the positive takeaway from the share price increase is that it doesn't take much to move this stock in either direction. If and I repeat if mccoy is still alive and funding somehow comes to rgin this could make a really impressive move to the upside. I have little hope of this occurring but maybe hell will freeze over and ole fatboy actually comes thru for once.

Let's hope that sausage is not in the punchbowl.

1 4000 share buy way above the bid doesnt spell any accomplishments by McCoy. If the "funding" came through we'd see THOUSANDS of shares trading hands.

Longs know someone is smoking hopium

Up to a nickel on low volume. If it is sheik passadasausage at work here I hope he keeps passin da sausage.

the arab shiek passdasausage probably funded something Randy sold him on like Camel collagen gelato

OK...what happened? We jumped up nicely today. What's going on?

Call me a pessimist but on past form, the Suntrust transaction will turn out to be some kind of shady contra.

Nothing will happen in this ticker until $ flows---FINANCING.
They are looking for fianancing for three years.Wow!We are in dark.No communication.Hope for the best.

https://ih.advfn.com/stock-market/USOTC/regenicin-inc-pc-RGIN/stock-news/79271766/statement-of-ownership-sc-13g?_ga=2.49551974.1319945093.1550422987-87778604.1538099608

Why is this signed February 2019? I'm confused. The 10 million posted below by stkmaniac was given to another company called health care co.

From year 2017
https://www.sec.gov/Archives/edgar/data/1412659/000107997317000200/lazarus_13g-bsc.htm

Sun Trust bank has owned these 10M shares for a while, I think at least a year or so. we just never saw any announcement of how they were acquired. Obviously not bought in the open market because have not even traded that many shares, plus we would be higher in price with that many shares purchased. My guess they got some cash or they did some accounting work or something like that We don't know what price they were given at, if there are restrictions on selling or anything. I heard after the AMBS deal the cone of silence was lifted. Well no news EVER!!!!!!!
It has been 8 years now. So I would think thousands of burn victims are being treated with current technology and doing fine. If this was so great it would of been funded by now. We can only hope (which is never a good investment strategy) that things are at least progressing, but oh so slowly...

Definitely. I don't see suntrust jumping in here if this was going under. Big positive. Especially where this has been with the last year or 2 of radio silence.

New money is what we have been waiting to see. I read it as positive news.

Not sure unfortunately. I'm in the dark just like the rest of us. I also like what I'm hearing from configman because I actually heard a similar thing from a source that they are waiting on money that is being held up.

hans, any thoughts on how long such a development will take to impact operations and sp? TIA....agree this is positive.

Looks like suntrust is an institutional investor now with 10 million shares owning 6.5% of outstanding. Good sign. At least something is happening finally.

Interesting...

https://ih.advfn.com/stock-market/USOTC/regenicin-inc-pc-RGIN/stock-news/79271766/statement-of-ownership-sc-13g

The Brooklyn Court comment might link to a comment I heard that they are suing Citigroup for 134 million. Something about money they are holding and won't release. Supposedly Morgan Stanley is a player in this drama also.

Brooklyn court records? What are you talking about. Have a link you can post?

Check Brooklyn court records on Jan 23rd....

Configman - I don't think he is doing anything against the new rules. The problem is that he and his team of Discala type brokers and advisors now face a tricky path in terms of how they sell stocks like RGIN. They have a legal duty to disclose things they didn't have to before. So the shares will tend to find their true market value as opposed to the pumped price.

Have not heard anything from NZ for a while. Just looked at their NZ website, they no longer falsely claim on that to own the Hikurangi facility, although McCoys own website does still make that false claim. The NZ website still implies they have assets etc there when they have nothing as far as my information says.

Cover axles~??$RGIN

Agree...very good question...WTF?

As much as Mccoy is to blame for this awful stock price, who is the moron selling at one penny? What's the point?